For decades, the dream of fixing harmful mutations in mitochondrial DNA felt out of reach. Scientists have long known these ...

The International Human Frontier Science Program Organization (HFSPO) is pleased to award the 2026 HFSP Nakasone Award to ...

HFSPO is pleased to award the 2026 HFSP Nakasone Award to Erin Schuman for her breakthrough related to the function and ...

RNA Victoria funds 2 Florey projects to prevent and treat Alzheimer's diseaseKey points mRNA Victoria has funded 2 Alzheimer's disease research ...

Technology can be harnessed to design novel and enhanced molecules that address challenges in biotechnology or medicine.

The mRNA therapeutics field is rapidly evolving beyond vaccines to include treatments for cancer, genetic disorders and in vivo cell therapies, bringing with it diverse production challenges. As the ...

The International Human Frontier Science Program Organization (HFSPO) is awarding the 2026 HFSP Nakasone Award to Erin Schuman for her breakthrough related to the function and plasticity of neuronal ...

The International Human Frontier Science Program Organization (HFSPO) is pleased to award the 2026 HFSP Nakasone Award to Erin Schuman for her ...

No longer a mere assistant who carries out the commands of DNA, RNA takes the lead in emerging therapeutics.

Professor Hirohide Saito and his research team have developed a new microRNA-responsive hybrid mRNA switch, enabling precise, ...